Komori
Revision of earnings forecasts4516Nippon Shinyaku Co.,Ltd.Pharmaceuticals

Third-Quarter Financial Results for the Fiscal Year Ending March 2026 [IFRS] (Consolidated)

2026年3月期通期の連結売上収益予想を1,680億円から1,700億円へ引き上げた。営業利益、税引前利益、親会社の所有者に帰属する当期利益、1株当たり利益および配当予想は据え置いた。

Worth reading
45Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
2000
¥ million
Wording
Conditional
How definitive the wording is.

Revised forecast

Fiscal year ending March 2026 · Full yearPrevious forecast published 14 November 2025
Net Sales168,000→170,000million
+1.2%
Operating profit33,000→33,000million
0.0%
Profit attributable to owners of the parent26,300→26,300million
0.0%
Net income per share390.2→390.2yen and sen
0.0%

The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.

Reason for the revision

第4四半期の為替レートの想定を1ドル140円から150円に変更したことなどにより、通期の売上収益は前回発表予想を上回る見込みとなった。

Previous-period results売上収益:160,232百万円(2025年3月期、補足情報)。通期の利益実績はNot disclosed
Dividend forecast revisionNo revision
Consolidated / non-consolidatedConsolidated
Revised forecast
ItemDetails
Net Sales¥168,000 million → ¥170,000 million(+1.2%)
Operating profit¥33,000 million → ¥33,000 million
Profit attributable to owners of the parent¥26,300 million → ¥26,300 million
Net income per share390.2 yen and sen → 390.2 yen and sen
Fiscal Period CoveredFiscal year ending March 2026
Period CoveredFull year
Publication date of previous forecast14 November 2025
Previous-period results売上収益:160,232百万円(2025年3月期、補足情報)。通期の利益実績はNot disclosed
Reason for the revision第4四半期の為替レートの想定を1ドル140円から150円に変更したことなどにより、通期の売上収益は前回発表予想を上回る見込みとなった。
Dividend forecast revisionNo revision
Consolidated / non-consolidatedConsolidated
Items this document does not state (2)
Ordinary incomeDetails and amount of extraordinary loss

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

第4四半期の為替レートの想定を1ドル140円から150円に変更したことなどにより、通期の売上収益が前回予想を上回る見込みとなったため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Third-Quarter Financial Results for the Fiscal Year Ending March 2026 [IFRS] (Consolidated) | Nippon Shinyaku Co.,Ltd. (4516) timely disclosure | Komori